Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 16 | 2025 | 447 | 3.020 |
Why?
|
Th1 Cells | 9 | 2025 | 159 | 2.120 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2025 | 441 | 1.760 |
Why?
|
Cancer Vaccines | 5 | 2021 | 189 | 1.460 |
Why?
|
Tumor Microenvironment | 5 | 2025 | 680 | 1.410 |
Why?
|
Immunologic Memory | 3 | 2021 | 198 | 1.340 |
Why?
|
Cytokines | 4 | 2025 | 1396 | 1.200 |
Why?
|
CTLA-4 Antigen | 2 | 2020 | 68 | 1.190 |
Why?
|
Amino Acyl-tRNA Synthetases | 3 | 2024 | 26 | 1.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2021 | 522 | 1.130 |
Why?
|
Immunotherapy | 7 | 2019 | 738 | 1.050 |
Why?
|
Neoplasms | 10 | 2025 | 3006 | 0.960 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2025 | 6 | 0.960 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2020 | 90 | 0.960 |
Why?
|
Fetal Blood | 9 | 2013 | 179 | 0.940 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2020 | 112 | 0.930 |
Why?
|
Adaptive Immunity | 2 | 2015 | 97 | 0.900 |
Why?
|
T-Lymphocytes | 8 | 2020 | 1801 | 0.770 |
Why?
|
Immunity, Innate | 2 | 2015 | 406 | 0.770 |
Why?
|
Dog Diseases | 2 | 2020 | 61 | 0.750 |
Why?
|
Homeostasis | 2 | 2024 | 751 | 0.720 |
Why?
|
Receptors, IgG | 1 | 2021 | 64 | 0.690 |
Why?
|
CD40 Antigens | 2 | 2012 | 27 | 0.690 |
Why?
|
Immune System | 1 | 2020 | 98 | 0.660 |
Why?
|
Immunity, Cellular | 2 | 2020 | 216 | 0.640 |
Why?
|
Vaccination | 5 | 2019 | 1009 | 0.630 |
Why?
|
Hemangiosarcoma | 1 | 2019 | 47 | 0.600 |
Why?
|
Animals | 37 | 2025 | 36265 | 0.600 |
Why?
|
Doxorubicin | 1 | 2019 | 305 | 0.550 |
Why?
|
Chagas Cardiomyopathy | 1 | 2017 | 53 | 0.540 |
Why?
|
Peptides | 3 | 2020 | 861 | 0.540 |
Why?
|
Antigens, Neoplasm | 4 | 2025 | 406 | 0.530 |
Why?
|
Neoplasm Proteins | 2 | 2025 | 717 | 0.520 |
Why?
|
Bystander Effect | 1 | 2016 | 6 | 0.520 |
Why?
|
B7 Antigens | 1 | 2016 | 14 | 0.510 |
Why?
|
Antigen-Presenting Cells | 3 | 2013 | 133 | 0.500 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2017 | 170 | 0.500 |
Why?
|
Porins | 6 | 2001 | 41 | 0.490 |
Why?
|
Respiratory Hypersensitivity | 1 | 2015 | 53 | 0.470 |
Why?
|
Cytosol | 1 | 2015 | 168 | 0.470 |
Why?
|
Immunomodulation | 2 | 2024 | 83 | 0.440 |
Why?
|
Mice | 26 | 2025 | 18815 | 0.420 |
Why?
|
Adenocarcinoma | 1 | 2021 | 1074 | 0.420 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 1084 | 0.410 |
Why?
|
Interferon-gamma | 8 | 2017 | 539 | 0.410 |
Why?
|
Stress, Physiological | 1 | 2015 | 270 | 0.400 |
Why?
|
Vaccines | 1 | 2017 | 377 | 0.390 |
Why?
|
Viral Hepatitis Vaccines | 1 | 2011 | 19 | 0.370 |
Why?
|
AIDS Vaccines | 1 | 2011 | 30 | 0.370 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 177 | 0.360 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 607 | 0.350 |
Why?
|
Th2 Cells | 2 | 2007 | 191 | 0.320 |
Why?
|
Influenza Vaccines | 3 | 2012 | 491 | 0.320 |
Why?
|
Humans | 43 | 2025 | 133290 | 0.320 |
Why?
|
Adjuvants, Immunologic | 1 | 2011 | 390 | 0.320 |
Why?
|
Mice, Inbred C57BL | 6 | 2025 | 4786 | 0.320 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 383 | 0.310 |
Why?
|
Killer Cells, Natural | 3 | 2021 | 353 | 0.310 |
Why?
|
Immunocompromised Host | 1 | 2010 | 304 | 0.290 |
Why?
|
Exotoxins | 1 | 2007 | 45 | 0.290 |
Why?
|
Anthrax Vaccines | 1 | 2007 | 26 | 0.280 |
Why?
|
Anthrax | 1 | 2007 | 31 | 0.280 |
Why?
|
Influenza, Human | 2 | 2012 | 686 | 0.280 |
Why?
|
Bacillus anthracis | 1 | 2007 | 40 | 0.280 |
Why?
|
Communicable Diseases | 1 | 2009 | 164 | 0.270 |
Why?
|
Cell Polarity | 1 | 2007 | 126 | 0.270 |
Why?
|
Bacterial Toxins | 1 | 2007 | 177 | 0.260 |
Why?
|
Plasmids | 1 | 2007 | 525 | 0.260 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2025 | 137 | 0.250 |
Why?
|
Cells, Cultured | 8 | 2019 | 3171 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2008 | 712 | 0.250 |
Why?
|
Antigens, Bacterial | 1 | 2007 | 320 | 0.240 |
Why?
|
Vaccines, DNA | 1 | 2005 | 49 | 0.240 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2025 | 127 | 0.240 |
Why?
|
Antigens, CD34 | 6 | 2012 | 111 | 0.240 |
Why?
|
RNA, Messenger | 3 | 2008 | 2896 | 0.230 |
Why?
|
Plasma Cells | 1 | 2025 | 57 | 0.230 |
Why?
|
Cell Line, Tumor | 5 | 2025 | 3719 | 0.230 |
Why?
|
Immunoassay | 1 | 2025 | 139 | 0.230 |
Why?
|
Ion Channels | 4 | 1999 | 206 | 0.220 |
Why?
|
Antigens, CD | 6 | 2009 | 451 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2010 | 567 | 0.220 |
Why?
|
Cell Differentiation | 2 | 2011 | 2027 | 0.220 |
Why?
|
Cigarette Smoking | 1 | 2025 | 79 | 0.220 |
Why?
|
Tobacco Smoke Pollution | 1 | 2025 | 94 | 0.220 |
Why?
|
Antibodies | 1 | 2005 | 382 | 0.210 |
Why?
|
Cluster Analysis | 1 | 2025 | 438 | 0.210 |
Why?
|
Interleukin Receptor Common gamma Subunit | 3 | 2013 | 12 | 0.210 |
Why?
|
Lymphocyte Activation | 5 | 2009 | 724 | 0.200 |
Why?
|
Cell Proliferation | 5 | 2015 | 2535 | 0.200 |
Why?
|
Glutathione Peroxidase | 1 | 2022 | 54 | 0.200 |
Why?
|
Lung Neoplasms | 2 | 2025 | 1790 | 0.200 |
Why?
|
Leukocytes, Mononuclear | 3 | 2021 | 355 | 0.190 |
Why?
|
Vaccines, Synthetic | 2 | 2017 | 322 | 0.190 |
Why?
|
Sezary Syndrome | 2 | 2014 | 14 | 0.190 |
Why?
|
Carcinogenesis | 2 | 2015 | 361 | 0.190 |
Why?
|
Dogs | 2 | 2020 | 798 | 0.180 |
Why?
|
Disease Models, Animal | 5 | 2020 | 4746 | 0.180 |
Why?
|
Alternative Splicing | 3 | 2000 | 374 | 0.180 |
Why?
|
Adenoviridae | 2 | 2017 | 609 | 0.180 |
Why?
|
Immunophenotyping | 3 | 2019 | 341 | 0.180 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2013 | 62 | 0.170 |
Why?
|
Cannabidiol | 1 | 2020 | 22 | 0.170 |
Why?
|
Exons | 2 | 2000 | 833 | 0.170 |
Why?
|
History, 19th Century | 2 | 2011 | 119 | 0.170 |
Why?
|
Mitochondria, Muscle | 1 | 2000 | 38 | 0.170 |
Why?
|
Arthralgia | 1 | 2020 | 59 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2025 | 2114 | 0.170 |
Why?
|
Multiple Myeloma | 2 | 2013 | 200 | 0.160 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 215 | 0.160 |
Why?
|
Sensitivity and Specificity | 1 | 2025 | 2162 | 0.160 |
Why?
|
Head and Neck Neoplasms | 1 | 2025 | 692 | 0.160 |
Why?
|
Bone Marrow Purging | 2 | 2011 | 34 | 0.160 |
Why?
|
Neuroblastoma | 1 | 2024 | 539 | 0.150 |
Why?
|
Osteoarthritis | 1 | 2020 | 103 | 0.150 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 649 | 0.150 |
Why?
|
Amino Acid Sequence | 4 | 2020 | 2785 | 0.150 |
Why?
|
History, 20th Century | 2 | 2011 | 397 | 0.150 |
Why?
|
Intracellular Space | 2 | 2016 | 52 | 0.150 |
Why?
|
Monte Carlo Method | 1 | 2019 | 100 | 0.150 |
Why?
|
Transduction, Genetic | 2 | 2017 | 296 | 0.150 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 278 | 0.150 |
Why?
|
Membrane Glycoproteins | 3 | 2012 | 432 | 0.140 |
Why?
|
Interleukin-12 | 2 | 2009 | 122 | 0.140 |
Why?
|
Reproducibility of Results | 1 | 2025 | 3057 | 0.140 |
Why?
|
Macrophages | 2 | 2015 | 709 | 0.140 |
Why?
|
CD3 Complex | 4 | 2013 | 93 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2017 | 506 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2015 | 497 | 0.140 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 81 | 0.130 |
Why?
|
Prognosis | 2 | 2025 | 5065 | 0.130 |
Why?
|
Drug Carriers | 1 | 2017 | 117 | 0.130 |
Why?
|
Signal Transduction | 3 | 2020 | 4881 | 0.130 |
Why?
|
CD40 Ligand | 2 | 2007 | 65 | 0.130 |
Why?
|
Antigen Presentation | 3 | 2015 | 117 | 0.130 |
Why?
|
Biomarkers, Tumor | 1 | 2025 | 1705 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 2 | 2011 | 563 | 0.130 |
Why?
|
Voltage-Dependent Anion Channels | 6 | 2001 | 32 | 0.120 |
Why?
|
Female | 10 | 2025 | 71345 | 0.120 |
Why?
|
Peptide Elongation Factors | 1 | 2015 | 13 | 0.120 |
Why?
|
Cell Separation | 4 | 2011 | 234 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2015 | 247 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 258 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 231 | 0.120 |
Why?
|
Immunological Synapses | 2 | 2012 | 27 | 0.120 |
Why?
|
Monocytes | 2 | 2016 | 361 | 0.120 |
Why?
|
Carcinogens, Environmental | 1 | 2015 | 15 | 0.120 |
Why?
|
Cell Cycle Checkpoints | 1 | 2015 | 62 | 0.120 |
Why?
|
Hazardous Substances | 1 | 2015 | 17 | 0.120 |
Why?
|
Receptors, Pattern Recognition | 1 | 2015 | 3 | 0.120 |
Why?
|
Immune Evasion | 1 | 2015 | 35 | 0.120 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 1314 | 0.120 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 142 | 0.120 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 508 | 0.120 |
Why?
|
Dinoprostone | 2 | 2022 | 85 | 0.120 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 395 | 0.120 |
Why?
|
Mycosis Fungoides | 1 | 2014 | 15 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 2658 | 0.110 |
Why?
|
Flow Cytometry | 4 | 2012 | 835 | 0.110 |
Why?
|
Skin Neoplasms | 2 | 2014 | 905 | 0.110 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 714 | 0.110 |
Why?
|
Survival Analysis | 1 | 2017 | 1596 | 0.110 |
Why?
|
Genetic Vectors | 1 | 2017 | 967 | 0.110 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2013 | 277 | 0.100 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 406 | 0.100 |
Why?
|
Environmental Exposure | 1 | 2015 | 244 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2012 | 817 | 0.100 |
Why?
|
Influenza in Birds | 1 | 2012 | 29 | 0.100 |
Why?
|
Lipopolysaccharide Receptors | 2 | 2009 | 53 | 0.100 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2012 | 10 | 0.100 |
Why?
|
Precision Medicine | 1 | 2015 | 358 | 0.100 |
Why?
|
Fucose | 1 | 2012 | 22 | 0.100 |
Why?
|
Vaccines, Inactivated | 1 | 2012 | 147 | 0.100 |
Why?
|
Mitochondria | 5 | 2001 | 738 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2025 | 988 | 0.100 |
Why?
|
Protein Isoforms | 4 | 2001 | 427 | 0.090 |
Why?
|
Influenza A virus | 1 | 2013 | 151 | 0.090 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2009 | 46 | 0.090 |
Why?
|
Cell Movement | 1 | 2015 | 919 | 0.090 |
Why?
|
Molecular Sequence Data | 6 | 2012 | 3970 | 0.090 |
Why?
|
HLA Antigens | 1 | 2012 | 251 | 0.090 |
Why?
|
History, 18th Century | 1 | 2011 | 70 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 63 | 0.090 |
Why?
|
Protein Multimerization | 1 | 2012 | 141 | 0.090 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 34 | 0.090 |
Why?
|
Boronic Acids | 1 | 2011 | 47 | 0.090 |
Why?
|
Pyrazines | 1 | 2011 | 74 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2011 | 90 | 0.090 |
Why?
|
Wnt Signaling Pathway | 1 | 2012 | 205 | 0.090 |
Why?
|
Orthomyxoviridae | 1 | 2010 | 52 | 0.080 |
Why?
|
History, 21st Century | 1 | 2011 | 278 | 0.080 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2014 | 555 | 0.080 |
Why?
|
Mice, SCID | 4 | 2013 | 612 | 0.080 |
Why?
|
Transplantation, Autologous | 2 | 2011 | 286 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 343 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2015 | 1328 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2012 | 273 | 0.080 |
Why?
|
Interleukin-6 | 2 | 2008 | 452 | 0.070 |
Why?
|
Antigens, Viral | 1 | 2010 | 440 | 0.070 |
Why?
|
Glycerol Kinase | 2 | 1999 | 19 | 0.070 |
Why?
|
Langerhans Cells | 1 | 2008 | 21 | 0.070 |
Why?
|
Immunoglobulins | 1 | 2009 | 176 | 0.070 |
Why?
|
Transfection | 2 | 2008 | 1090 | 0.070 |
Why?
|
K562 Cells | 3 | 2014 | 100 | 0.070 |
Why?
|
Inflammation | 1 | 2015 | 1599 | 0.070 |
Why?
|
Epitopes | 1 | 2009 | 446 | 0.070 |
Why?
|
Protein Subunits | 1 | 2007 | 174 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2008 | 169 | 0.070 |
Why?
|
X Chromosome | 2 | 1999 | 342 | 0.070 |
Why?
|
Mice, Inbred NOD | 3 | 2013 | 316 | 0.070 |
Why?
|
Species Specificity | 1 | 2007 | 571 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2008 | 191 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 1844 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2009 | 676 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2006 | 41 | 0.060 |
Why?
|
Myocardium | 1 | 2011 | 1057 | 0.060 |
Why?
|
Evolution, Molecular | 2 | 1999 | 710 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2006 | 83 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 86 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2006 | 82 | 0.060 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 100 | 0.060 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2005 | 47 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 1069 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2005 | 109 | 0.060 |
Why?
|
Smoke | 1 | 2025 | 67 | 0.060 |
Why?
|
Neoplasm Transplantation | 1 | 2005 | 398 | 0.060 |
Why?
|
Biomedical Research | 1 | 2010 | 555 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 250 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2017 | 12957 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 256 | 0.050 |
Why?
|
Male | 8 | 2021 | 65619 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 1 | 2010 | 867 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2011 | 1084 | 0.050 |
Why?
|
Cellular Reprogramming | 1 | 2025 | 134 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 2214 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 774 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2007 | 926 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 1068 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 1911 | 0.050 |
Why?
|
Interleukin-2 | 2 | 2013 | 250 | 0.050 |
Why?
|
Base Sequence | 3 | 2000 | 3169 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 1150 | 0.040 |
Why?
|
Sperm Motility | 1 | 2001 | 107 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2017 | 538 | 0.040 |
Why?
|
Cell Culture Techniques | 2 | 2013 | 292 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2014 | 78 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2005 | 866 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2000 | 295 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 7184 | 0.040 |
Why?
|
Cannabis | 1 | 2020 | 51 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2000 | 206 | 0.040 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2000 | 62 | 0.040 |
Why?
|
ErbB Receptors | 1 | 2021 | 302 | 0.040 |
Why?
|
Cell Survival | 3 | 2011 | 892 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2013 | 246 | 0.040 |
Why?
|
Lod Score | 1 | 1999 | 128 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2013 | 3957 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2025 | 860 | 0.040 |
Why?
|
Retroelements | 1 | 1999 | 41 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1999 | 71 | 0.040 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1999 | 82 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2000 | 298 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 1999 | 1124 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2025 | 2525 | 0.040 |
Why?
|
Biomarkers | 1 | 2009 | 3402 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 123 | 0.040 |
Why?
|
Cell Lineage | 2 | 2012 | 369 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2000 | 633 | 0.040 |
Why?
|
Infertility, Male | 1 | 2001 | 287 | 0.040 |
Why?
|
Genetic Linkage | 1 | 1999 | 480 | 0.040 |
Why?
|
Genetic Markers | 1 | 1999 | 630 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2013 | 1439 | 0.030 |
Why?
|
Pericytes | 1 | 2017 | 24 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2017 | 104 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 77 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2001 | 1050 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2020 | 1666 | 0.030 |
Why?
|
Voltage-Dependent Anion Channel 1 | 3 | 2001 | 24 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2017 | 241 | 0.030 |
Why?
|
Phytochemicals | 1 | 2015 | 9 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 110 | 0.030 |
Why?
|
Receptors, CCR4 | 1 | 2014 | 7 | 0.030 |
Why?
|
Tumor Escape | 1 | 2015 | 65 | 0.030 |
Why?
|
DNA | 1 | 2000 | 1663 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2015 | 157 | 0.030 |
Why?
|
Adult | 2 | 2012 | 31851 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2013 | 1 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 1 | 2013 | 3 | 0.030 |
Why?
|
CD56 Antigen | 1 | 2013 | 28 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 1834 | 0.030 |
Why?
|
United States | 1 | 2009 | 11633 | 0.030 |
Why?
|
Blotting, Western | 3 | 2001 | 1138 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2013 | 11 | 0.030 |
Why?
|
Influenza A Virus, H9N2 Subtype | 1 | 2012 | 12 | 0.030 |
Why?
|
Influenza A Virus, H7N7 Subtype | 1 | 2012 | 11 | 0.030 |
Why?
|
Aged | 3 | 2021 | 21619 | 0.030 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2012 | 115 | 0.020 |
Why?
|
Orthomyxoviridae Infections | 1 | 2013 | 63 | 0.020 |
Why?
|
Birds | 1 | 2012 | 87 | 0.020 |
Why?
|
Axin Protein | 1 | 2012 | 18 | 0.020 |
Why?
|
Casein Kinase I | 1 | 2012 | 12 | 0.020 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2012 | 61 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 369 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 382 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2009 | 1760 | 0.020 |
Why?
|
Dishevelled Proteins | 1 | 2012 | 45 | 0.020 |
Why?
|
Arabinofuranosyluracil | 1 | 2011 | 4 | 0.020 |
Why?
|
Lymphography | 1 | 2011 | 13 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2011 | 95 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2012 | 63 | 0.020 |
Why?
|
Lymphatic Vessels | 1 | 2011 | 37 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2011 | 34 | 0.020 |
Why?
|
Cell Line | 2 | 2011 | 2842 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 273 | 0.020 |
Why?
|
Magnetics | 1 | 2011 | 42 | 0.020 |
Why?
|
Bortezomib | 1 | 2011 | 71 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 29237 | 0.020 |
Why?
|
Spleen | 1 | 2012 | 291 | 0.020 |
Why?
|
CD2 Antigens | 1 | 2010 | 8 | 0.020 |
Why?
|
Receptor Aggregation | 1 | 2010 | 7 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 815 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 26 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2012 | 140 | 0.020 |
Why?
|
Membrane Proteins | 1 | 1998 | 1607 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 37 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 386 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2012 | 607 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 229 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 394 | 0.020 |
Why?
|
Rituximab | 1 | 2011 | 163 | 0.020 |
Why?
|
Stromal Cells | 1 | 2012 | 313 | 0.020 |
Why?
|
Voltage-Dependent Anion Channel 2 | 2 | 1999 | 17 | 0.020 |
Why?
|
Luciferases, Firefly | 1 | 2009 | 13 | 0.020 |
Why?
|
Luminescent Agents | 1 | 2009 | 6 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2009 | 61 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2012 | 453 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2011 | 400 | 0.020 |
Why?
|
Baculoviridae | 1 | 2009 | 68 | 0.020 |
Why?
|
Prostate | 1 | 2012 | 449 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 184 | 0.020 |
Why?
|
Models, Immunological | 1 | 2009 | 38 | 0.020 |
Why?
|
Receptor, EphA4 | 1 | 2008 | 5 | 0.020 |
Why?
|
Granzymes | 1 | 2008 | 48 | 0.020 |
Why?
|
Actins | 1 | 2010 | 353 | 0.020 |
Why?
|
Twist-Related Protein 1 | 1 | 2008 | 39 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 54 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 619 | 0.020 |
Why?
|
Brain | 1 | 2000 | 3206 | 0.020 |
Why?
|
Swine | 1 | 2011 | 1214 | 0.020 |
Why?
|
Phosphorylation | 1 | 2012 | 1701 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2009 | 227 | 0.020 |
Why?
|
Protein Binding | 1 | 2012 | 1831 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2009 | 992 | 0.020 |
Why?
|
DNA, Complementary | 2 | 1999 | 471 | 0.020 |
Why?
|
Mutation | 1 | 2021 | 6267 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2012 | 939 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 866 | 0.020 |
Why?
|
Neutrophils | 1 | 2009 | 404 | 0.020 |
Why?
|
Blood Platelets | 1 | 2009 | 340 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2012 | 1203 | 0.020 |
Why?
|
Imatinib Mesylate | 1 | 2006 | 50 | 0.020 |
Why?
|
AC133 Antigen | 1 | 2006 | 36 | 0.020 |
Why?
|
CD4 Antigens | 1 | 2006 | 58 | 0.020 |
Why?
|
Mothers | 1 | 2009 | 369 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 49 | 0.020 |
Why?
|
CD8 Antigens | 1 | 2006 | 45 | 0.020 |
Why?
|
Echocardiography | 1 | 2011 | 1113 | 0.020 |
Why?
|
CD28 Antigens | 1 | 2006 | 81 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2006 | 146 | 0.020 |
Why?
|
Benzamides | 1 | 2006 | 125 | 0.020 |
Why?
|
Phagocytosis | 1 | 2006 | 194 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 1614 | 0.010 |
Why?
|
Piperazines | 1 | 2006 | 257 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 1101 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2006 | 417 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 724 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1352 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 1533 | 0.010 |
Why?
|
Glycoproteins | 1 | 2006 | 378 | 0.010 |
Why?
|
Pyrimidines | 1 | 2006 | 419 | 0.010 |
Why?
|
Leukemia | 1 | 2006 | 377 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 1184 | 0.010 |
Why?
|
Electron Transport | 1 | 2001 | 56 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 270 | 0.010 |
Why?
|
Sperm Count | 1 | 2001 | 89 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2001 | 374 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 6562 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 404 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 1999 | 41 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 3836 | 0.010 |
Why?
|
Yeasts | 1 | 1999 | 43 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 1999 | 50 | 0.010 |
Why?
|
Eukaryotic Cells | 1 | 1999 | 32 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 1999 | 65 | 0.010 |
Why?
|
NAD | 1 | 1999 | 46 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 4518 | 0.010 |
Why?
|
Permeability | 1 | 1999 | 132 | 0.010 |
Why?
|
3T3 Cells | 1 | 1998 | 123 | 0.010 |
Why?
|
Ion Channel Gating | 1 | 1999 | 126 | 0.010 |
Why?
|
Gene Targeting | 1 | 1999 | 183 | 0.010 |
Why?
|
Electrophysiology | 1 | 1999 | 281 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1999 | 316 | 0.010 |
Why?
|
Liposomes | 1 | 1999 | 203 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1999 | 463 | 0.010 |
Why?
|
Models, Genetic | 1 | 2001 | 789 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 433 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1998 | 156 | 0.010 |
Why?
|
Introns | 1 | 1998 | 313 | 0.010 |
Why?
|
Testis | 1 | 1999 | 424 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2006 | 1190 | 0.010 |
Why?
|
COS Cells | 1 | 1996 | 283 | 0.010 |
Why?
|
RNA | 1 | 1999 | 602 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 8560 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 676 | 0.010 |
Why?
|